SCHEMBL6185597

SCHEMBL6185597

CC1CN(C(Oc2ccccc2F)C(C)O)CCN1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.39
MLNR O43193 2/20 0.38
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.35
THRB P10828 1/20 0.35
SLC6A2 P23975 6/20 0.35
SLC6A4 P31645 6/20 0.35
SLC6A3 Q01959 2/20 0.35
HPGD P15428 2/20 0.34
KCNH2 Q12809 4/20 0.34
CYP2D6 P10635 1/20 0.34
LMNA P02545 2/20 0.34
XIAP P98170 1/20 0.33
BIRC2 Q13490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6260656 0.83 SLC6A2 (0.45) ALDH1A1GAASLC6A2SLC6A4SLC6A3
SCHEMBL6192035 0.83 SLC6A2 (0.45) ALDH1A1GAASLC6A2SLC6A4SLC6A3
SCHEMBL6195075 0.72 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL4101638 0.70 HRH3 (0.39) HRH3SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4979530 0.70 HRH3 (0.39) HRH3SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL13725899 0.70 HRH3 (0.39) HRH3SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4866968 0.69 MEN1 (0.50) MLNRALDH1A1LMNA
SCHEMBL3634855 0.69 HTR6 (0.48) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL6193617 0.69 HTR6 (0.48) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL6195656 0.66 CYP3A4 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567525-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2005-08-31 EP disclosed
WO-2004052887-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-06-24 WO disclosed